| Literature DB >> 33679783 |
Wenxiao Jia1, Hui Zhu2, Qianqian Gao3, Jian Sun4, Fujian Tan5, Qun Liu5, Hongbo Guo1,4, Jinming Yu1,2.
Abstract
A 56-year-old male was diagnosed with right lung upper lobe squamous cancer with right hilar and mediastinum lymph node metastasis. After four cycles of neoadjuvant immunochemotherapy, reexamination by computed tomography showed progressive disease of the primary lesion. Then, the patient underwent a right lung upper lobectomy, and hilar and mediastinum lymph node dissection. Surgical pathology showed a partial response to immunochemotherapy. Single-cell RNA sequencing was used to characterize the infiltrating immune cell atlas after neoadjuvant immunochemotherapy; the most common infiltrating immune cell types were cytotoxic CD8+ T cells, monocyte-derived dendritic cells, and macrophages. Imaging mass cytometry revealed a transformation from cold to hot tumor after neoadjuvant immunochemotherapy. In this case study, we are the first to report a case of neoadjuvant immunochemotherapy pseudoprogression, proved by surgical pathology, single-cell RNA sequencing, and imaging mass cytometry. Both single-cell RNA sequencing and imaging mass cytometry revealed an activated immune microenvironment after neoadjuvant immunochemotherapy.Entities:
Keywords: NSCLC; imaging mass cytometry; immunotherapy; pseudoprogression; single-cell RNA-sequencing
Year: 2021 PMID: 33679783 PMCID: PMC7925896 DOI: 10.3389/fimmu.2021.633534
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561